Pasar al contenido principal

STENTS POLIMERICOS ADAPTABLES PARA TRATAR COARTACION AORTICA PEDIATRICA

PID2021-124868OB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITECNICA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Integrating stent design and microstructural characterization to improve clinical outcomes of bioresorbable stents

  • Canalejo-Codina, Francesc
  • PEGUEROLES, MARTA
  • Garcia Granada, Andres Amador
  • Martorell, Jordi
  • Edelman, Elazer
  • Balcells, Mercedes
Bioresorbable stents were conceived to revolutionize the treatment of cardiovascular diseases. However, their significant benefits were overshadowed by a higher clotting rate compared to permanent implants. This clinical failure is linked to strain-induced microstructural disruptions during fabrication and implantation, resulting in heterogeneous loss of structural integrity. The non-gradual loss of support, combined with faster, localized polymer deterioration, directly contributes to the clinical failure observed in bioresorbable stents. Leveraging this understanding marks a significant advancement toward their safe reintroduction. However, the extent to which a stent’s stress distribution interacts with the polymer’s microstructure remains understudied. This study advances the existing knowledge on bioresorbable stents by establishing a framework for comprehending the microstructural properties that emerge from stent fabrication and implantation, ultimately aiming to improve clinical outcomes. The analysis addresses structural degradation and thrombogenicity of the devices, linking these aspects to the microstructural characteristics of various poly(L-lactide-co-ε-caprolactone) stent configurations. The configuration with the polymer microstructure tailored to the stress profile of the stent design presented the best performance. These findings emphasize the critical need to align the as-manufactured material properties with the stress distribution during implantation and provide powerful tools and strategies to cast bioresorbable stents that outperform current cardiovascular stents., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

3D printed polymeric stent design: Mechanical testing and computational modeling

  • Canalejo-Codina, Francesc
  • Cano Morenilla, Mariola
  • Martorell López, Jordi
  • Balcells, Mercedes
  • Pegueroles, Marta
  • Garcia Granada, Andres Amador
Polymer-based bioresorbable scaffolds (BRS) aim to reduce the long-term issues associated with metal stents. Yet, first-generation BRS designs experienced a significantly higher rate of clinical failures compared to permanent implants. This prompted the development of alternative scaffolds, such as the poly(L-lactide-co-ε-caprolactone) (PLCL) solvent-casted stent, whose mechanical performance has yet to be addressed. This study examines the mechanical behavior of this novel scaffold across a wide range of parallel and radial compression diameters. The analysis highlights the scaffold’s varying responses under different loading conditions and provides insights into interpreting simulation model parameters to accurately reflect experimental results. Stents demonstrated a parallel crush resistance of 0.11 N/mm at maximum compression, whereas the radial forces were significantly higher, reaching up to 1.80 N/mm. Additionally, the parallel test keeps the stent in the elastic regime, with almost no regions exceeding 50 MPa of stress, while the radial test causes significant structural deformation, with localized plastic strain reaching up to 30 %. Results showed that underestimating yield strain in computational models leads to discrepancies with experimental results, being 5 % the most accurate value for matching computational and experimental results for PLCL solvent-casted stents. This comprehensive approach is vital for optimizing BRS design and predicting clinical performance., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Preclinical evaluation of pediatric polymeric stents in a minimally invasive rabbit model

  • Canalejo-Codina, Francesc
  • Cano Morenilla, Mariola
  • Bonich-Aranda, Mireia
  • López Campillo, Adrián
  • Yugueros, Xavier
  • Mestres, Gaspar
  • PEGUEROLES, MARTA
  • Edelman, Elazer
  • Garcia Granada, Andres Amador
  • Balcells, Mercedes
  • Martorell, Jordi
Stent implantation is standard treatment for pediatric aortic coarctation, but permanent metallic devices do not accommodate somatic growth, causing repeated interventions and long-term complications. Bioresorbable polymeric stents offer temporary support with progressive vascular adaptation, yet in vivo validation remains essential. This study evaluates the procedural performance and in vivo biocompatibility of a next-generation polymeric stent in a minimally invasive rabbit model. A microstructure-based auxetic (MBA) geometry fabricated from poly(L-lactide-co-ε-caprolactone) was optimized to a radial force of 0.98 N/mm at 0.55 maximum strain and implanted via a novel 6F femoral catheterization in New Zealand white rabbits, with solvent-cast direct-write (SCDW) polymeric and Cook Formula 418 metallic stents as controls. Of 24 animals, 22 received 39 stents, with follow-up at 30 min, 14 and 28 days. The implantation and explantation protocol proved feasible and reproducible. No MBA device was dislodged during delivery, vs 36.4% of SCDW devices (p = 0.004); migration did not differ between polymeric and metallic devices (p = 0.686). At 28 days, both platforms achieved complete endothelialization (5.00 ± 0.00), minimal vessel injury (0.33 ± 0.52) and preserved medial architecture. Strut integration was complete for MBA (5.00 ± 0.00) vs partial for SCDW (4.33 ± 0.82), and neointimal inflammation was minimal in both (MBA 1.00 ± 0.00; SCDW 1.17 ± 0.41). Transient mural thrombus at 14 days had resolved by 28 days. Neointimal area was comparable (MBA 2.44 ± 0.08 mm²; SCDW 2.24 ± 0.41 mm²), with higher stenosis in MBA arteries (32.72 ± 3.00% vs 20.85 ± 4.00%). These findings support the early biocompatibility of the MBA platform and validate the model for longitudinal assessment of pediatric vascular devices., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Preclinical evaluation of pediatric polymeric stents in a minimally invasive rabbit model

  • Canalejo-Codina, Francesc
  • Cano Morenilla, Mariola
  • Bonich-Aranda, Mireia
  • López Campillo, Adrián
  • Yugueros, Xavier
  • Mestres, Gaspar
  • PEGUEROLES, MARTA
  • Edelman, Elazer
  • Garcia Granada, Andres Amador
  • Balcells, Mercedes
  • Martorell, Jordi
Stent implantation is standard treatment for pediatric aortic coarctation, but permanent metallic devices do not accommodate somatic growth, causing repeated interventions and long-term complications. Bioresorbable polymeric stents offer temporary support with progressive vascular adaptation, yet in vivo validation remains essential. This study evaluates the procedural performance and in vivo biocompatibility of a next-generation polymeric stent in a minimally invasive rabbit model. A microstructure-based auxetic (MBA) geometry fabricated from poly(L-lactide-co-ε-caprolactone) was optimized to a radial force of 0.98 N/mm at 0.55 maximum strain and implanted via a novel 6F femoral catheterization in New Zealand white rabbits, with solvent-cast direct-write (SCDW) polymeric and Cook Formula 418 metallic stents as controls. Of 24 animals, 22 received 39 stents, with follow-up at 30 min, 14 and 28 days. The implantation and explantation protocol proved feasible and reproducible. No MBA device was dislodged during delivery, vs 36.4% of SCDW devices (p = 0.004); migration did not differ between polymeric and metallic devices (p = 0.686). At 28 days, both platforms achieved complete endothelialization (5.00 ± 0.00), minimal vessel injury (0.33 ± 0.52) and preserved medial architecture. Strut integration was complete for MBA (5.00 ± 0.00) vs partial for SCDW (4.33 ± 0.82), and neointimal inflammation was minimal in both (MBA 1.00 ± 0.00; SCDW 1.17 ± 0.41). Transient mural thrombus at 14 days had resolved by 28 days. Neointimal area was comparable (MBA 2.44 ± 0.08 mm²; SCDW 2.24 ± 0.41 mm²), with higher stenosis in MBA arteries (32.72 ± 3.00% vs 20.85 ± 4.00%). These findings support the early biocompatibility of the MBA platform and validate the model for longitudinal assessment of pediatric vascular devices., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

3D printed polymeric stent design: Mechanical testing and computational modeling

  • Canalejo-Codina, Francesc
  • Cano Morenilla, Mariola
  • Martorell López, Jordi
  • Balcells, Mercedes
  • Pegueroles, Marta
  • Garcia Granada, Andres Amador
Polymer-based bioresorbable scaffolds (BRS) aim to reduce the long-term issues associated with metal stents. Yet, first-generation BRS designs experienced a significantly higher rate of clinical failures compared to permanent implants. This prompted the development of alternative scaffolds, such as the poly(L-lactide-co-ε-caprolactone) (PLCL) solvent-casted stent, whose mechanical performance has yet to be addressed. This study examines the mechanical behavior of this novel scaffold across a wide range of parallel and radial compression diameters. The analysis highlights the scaffold’s varying responses under different loading conditions and provides insights into interpreting simulation model parameters to accurately reflect experimental results. Stents demonstrated a parallel crush resistance of 0.11 N/mm at maximum compression, whereas the radial forces were significantly higher, reaching up to 1.80 N/mm. Additionally, the parallel test keeps the stent in the elastic regime, with almost no regions exceeding 50 MPa of stress, while the radial test causes significant structural deformation, with localized plastic strain reaching up to 30 %. Results showed that underestimating yield strain in computational models leads to discrepancies with experimental results, being 5 % the most accurate value for matching computational and experimental results for PLCL solvent-casted stents. This comprehensive approach is vital for optimizing BRS design and predicting clinical performance., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Integrating stent design and microstructural characterization to improve clinical outcomes of bioresorbable stents

  • Canalejo-Codina, Francesc
  • PEGUEROLES, MARTA
  • Garcia Granada, Andres Amador
  • Martorell, Jordi
  • Edelman, Elazer
  • Balcells, Mercedes
Bioresorbable stents were conceived to revolutionize the treatment of cardiovascular diseases. However, their significant benefits were overshadowed by a higher clotting rate compared to permanent implants. This clinical failure is linked to strain-induced microstructural disruptions during fabrication and implantation, resulting in heterogeneous loss of structural integrity. The non-gradual loss of support, combined with faster, localized polymer deterioration, directly contributes to the clinical failure observed in bioresorbable stents. Leveraging this understanding marks a significant advancement toward their safe reintroduction. However, the extent to which a stent’s stress distribution interacts with the polymer’s microstructure remains understudied. This study advances the existing knowledge on bioresorbable stents by establishing a framework for comprehending the microstructural properties that emerge from stent fabrication and implantation, ultimately aiming to improve clinical outcomes. The analysis addresses structural degradation and thrombogenicity of the devices, linking these aspects to the microstructural characteristics of various poly(L-lactide-co-ε-caprolactone) stent configurations. The configuration with the polymer microstructure tailored to the stress profile of the stent design presented the best performance. These findings emphasize the critical need to align the as-manufactured material properties with the stress distribution during implantation and provide powerful tools and strategies to cast bioresorbable stents that outperform current cardiovascular stents., info:eu-repo/semantics/publishedVersion